Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | -0.52% | -5.87% | -9.84% |
May. 31 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
May. 07 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.84% | 213M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Barclays Adjusts Price Target on Prelude Therapeutics to $5 From $7, Maintains Equalweight Rating